» Articles » PMID: 33068045

ZEB1 and Oncogenic Ras Constitute a Regulatory Switch for Stimulus-dependent E-cadherin Downregulation

Overview
Journal Cancer Sci
Specialty Oncology
Date 2020 Oct 17
PMID 33068045
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

E-cadherin, an epithelial cell-specific cell adhesion molecule, has both promoting and suppressing effects on tumor invasion and metastasis. It is often downregulated during cancer progression through gene deletion/mutation, transcriptional repression, or epigenetic silencing. We describe a novel regulatory switch to induce stimulus-dependent downregulation of mRNA encoding E-cadherin (CDH1 mRNA) in KRAS-mutated cancer cells. The regulatory switch consists of ZEB1 and oncogenic K-Ras, does not target the promoter region of CDH1, and requires an external cue to temporally downregulate E-cadherin expression. Its repressive effect is maintained as long as the external stimulus continues and is attenuated with cessation of the stimulus. Contextual external cues that turn this regulatory switch on include activation of protein kinase C or fibroblast growth factor signaling. The mode of action is distinct from that of EPCAM repression by ZEB1, which does not require an external cue. Thus, KRAS-mutated cancer cells acquire a novel mode of regulating E-cadherin expression depending on ZEB1, which could contribute to phenotypic plasticity of cancer cells during malignant progression.

Citing Articles

Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment.

Jiang H Cancer Manag Res. 2025; 17:219-237.

PMID: 39912095 PMC: 11796448. DOI: 10.2147/CMAR.S495169.


Microgravity as a Tool to Investigate Cancer Induction in Pleura Mesothelial Cells.

Bonetto V, Pagano C, Sabbatini M, Magnelli V, Donadelli M, Marengo E Curr Issues Mol Biol. 2024; 46(10):10896-10912.

PMID: 39451527 PMC: 11506709. DOI: 10.3390/cimb46100647.


Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors.

Imodoye S, Adedokun K, Muhammed A, Bello I, Muhibi M, Oduola T Front Oncol. 2021; 11:762817.

PMID: 34868979 PMC: 8636732. DOI: 10.3389/fonc.2021.762817.


MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer.

Bai S, Sun Y, Cheng Y, Ye W, Jiang C, Liu M J Nanobiotechnology. 2021; 19(1):367.

PMID: 34789268 PMC: 8600743. DOI: 10.1186/s12951-021-01115-9.


Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review.

Kolanska K, Bendifallah S, Canlorbe G, Mekinian A, Touboul C, Aractingi S J Clin Med. 2021; 10(16).

PMID: 34441754 PMC: 8396961. DOI: 10.3390/jcm10163457.


References
1.
Ohira T, Gemmill R, Ferguson K, Kusy S, Roche J, Brambilla E . WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci U S A. 2003; 100(18):10429-34. PMC: 193578. DOI: 10.1073/pnas.1734137100. View

2.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D . miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010; 12(3):247-56. PMC: 2845545. DOI: 10.1038/ncb2024. View

3.
de Leeuw W, Berx G, Vos C, Peterse J, van de Vijver M, Litvinov S . Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1998; 183(4):404-11. DOI: 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9. View

4.
Prior I, Lewis P, Mattos C . A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012; 72(10):2457-67. PMC: 3354961. DOI: 10.1158/0008-5472.CAN-11-2612. View

5.
Kang X, Lin Z, Xu M, Pan J, Wang Z . Deciphering role of FGFR signalling pathway in pancreatic cancer. Cell Prolif. 2019; 52(3):e12605. PMC: 6536421. DOI: 10.1111/cpr.12605. View